Specialized diagnosis and hospital-grade clinical therapies for chronic inflammatory skin disorders, autoimmune conditions, and malignant lesion screening.
Specialized medical pathways including oral isotretinoin (Accutane) monitoring, systemic antibiotics, topical prescription compounds, and vascular laser treatments to target inflammatory papules and chronic erythema.
Comprehensive systemic management utilizing targeted biologic therapies (anti-IL-17, anti-IL-23, JAK inhibitors) and dedicated nursing injection support for severe plaque psoriasis and chronic eczema refractory to standard creams.
Safe, hospital-grade ultraviolet light cabins providing calibrated wavelengths (311nm) that suppress hyperactive dermal immune cells without the systemic side effects of oral medications. Available at our Edmonton clinic.
High-magnification polarized dermoscopy and biopsy triage for suspected basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and malignant melanoma. Expedited pathology reviews and surgical excise referrals.
Stratica is proud to host a dedicated Clinical Research Division conducting Phase II, III, and IV international clinical trials right here in Edmonton. Qualified participants receive study-related investigational therapies, physician monitoring, and diagnostic tests at zero out-of-pocket cost.
Ask to speak with a Clinical Study Coordinator to assess eligibility for ongoing clinical research programs.
Inquire About Trials →Consult your family physician or walk-in clinic doctor regarding your skin condition.
Your doctor faxes the referral letter with relevant charts to our central medical intake: (780) 428-5556.
Our dermatologists triage urgency within 48-72 business hours and contact you directly with an appointment date.